Venn Life Sciences Overview

  • Founded
  • 2007
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 170
Employees
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 7
  • Investments
  • 9

Venn Life Sciences General Information

Description

Open Orphan PLC is a European-focused, rare and orphan drug consulting services platform. The company consists of four elements: a European clinical research organization and consultancy; an orphan drug services business; a Virtual Rep and Data Access Platform consisting of physicians and key opinion leaders; and a Health Data Platform to partner with Patient Advocacy Groups. The company is targeting rapid growth in one of the fastest growing sectors in the global pharmaceutical industry targeting under-supplied treatment for life threatening or very serious diseases and rare disorders.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Healthcare Services
Other Industries
Drug Discovery
Acquirer
Open Orphan
Primary Office
  • 18 Upper Mount Street
  • Dublin D02 ER26
  • Ireland
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Venn Life Sciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Venn Life Sciences‘s full profile, request access.

Request a free trial

Venn Life Sciences Executive Team (15)

Name Title Board Seat Contact Info
Anthony Richardson Chief Executive Officer & Board Member
Trevor Phillips Ph.D Chief Executive Officer & Board Member
Christian Milla Ph.D Chief Operating Officer
Jonathan Hartshorn Chief Financial Officer & Board Member
You’re viewing 4 of 15 executive team members. Get the full list »

Venn Life Sciences Board Members (15)

Name Representing Role Since
0000000 0000000000 Venn Life Sciences Chief Executive Officer & Board Member 000 0000
000000000 00000 00.0 Venn Life Sciences Chief Operating Officer 000 0000
00000000 000000000 Self Chief Financial Officer & Board Member 000 0000
0000 00000 00.0 Self Board Member 000 0000
000000 00000000 00.0 Venn Life Sciences Chief Executive Officer & Board Member 000 0000
You’re viewing 5 of 15 board members. Get the full list »

Venn Life Sciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Venn Life Sciences Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Venn Life Sciences‘s full profile, request access.

Request a free trial

Venn Life Sciences Investments & Acquisitions (9)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 05-Apr-2017 000 00.000 Personal Products
0000000 000000 16-Oct-2015 000000000000000000 00.000 Consulting Services (B2B) 0000000 0000000000
00000000 0000000 0 05-Aug-2014 000000000000000000 00000 Consulting Services (B2B) 0000000 0000000000
00000000 (0000000 28-Feb-2014 000000000 00000 00 00000 Buildings and Property 0000000 0000000000
Venn Life Sciences Germany 13-Jan-2014 Merger/Acquisition 00000 Other Healthcare Services
You’re viewing 5 of 9 investments and acquisitions. Get the full list »

Venn Life Sciences Subsidiaries (1)

Company Name Industry Location Founded
0000 0000 00000000 Other Healthcare Services Rheinbach, Germany 0000
To view Venn Life Sciences’s complete subsidiaries history, request access »

Venn Life Sciences Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000000 05-Apr-2017 000 00.000 Completed
  • 0000 0000 00000000
To view Venn Life Sciences’s complete exits history, request access »